Published in Am J Epidemiol on June 15, 2004
Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med (2011) 10.33
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol (2009) 10.18
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA (2008) 4.48
Clinical features of colorectal cancer before diagnosis: a population-based case-control study. Br J Cancer (2005) 4.19
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia (2011) 3.52
Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care (2009) 2.90
Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol (2010) 2.79
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer (2011) 2.30
Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer (2011) 2.23
Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus. J Clin Oncol (2014) 2.21
Diabetes and lung cancer among postmenopausal women. Diabetes Care (2012) 2.17
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer (2010) 2.04
Metformin: multi-faceted protection against cancer. Oncotarget (2011) 2.00
Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ (2012) 1.95
Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J (2004) 1.94
Association of albuminuria and cancer incidence. J Am Soc Nephrol (2008) 1.91
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med (2009) 1.83
Risk of cancer following hospitalization for type 2 diabetes. Oncologist (2010) 1.75
Diabetes and pancreatic cancer. Mol Carcinog (2012) 1.71
Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling. Cell (2013) 1.69
Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proc Natl Acad Sci U S A (2005) 1.59
Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol (2009) 1.58
A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer (2009) 1.56
Diabetes and urothelial cancer risk: the Multiethnic Cohort study. Cancer Epidemiol (2011) 1.54
The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res (2012) 1.53
Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer (2011) 1.48
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. Ann Oncol (2011) 1.45
Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care (2012) 1.42
Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. Ann Oncol (2011) 1.41
Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci (2008) 1.38
Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors. J Clin Invest (2006) 1.38
Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med (2008) 1.38
The link between the metabolic syndrome and cancer. Int J Biol Sci (2011) 1.37
Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease. World J Gastroenterol (2009) 1.33
Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol (2009) 1.30
Diabetes and breast cancer risk: a meta-analysis. Br J Cancer (2012) 1.30
Dietary and metabolic control of stem cell function in physiology and cancer. Cell Stem Cell (2014) 1.29
Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression. Diabetes (2009) 1.28
A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer (2005) 1.23
Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition. EMBO J (2010) 1.23
Human pyruvate kinase M2: a multifunctional protein. Protein Sci (2010) 1.23
Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol (2011) 1.20
Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci (2010) 1.17
Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol (2010) 1.16
Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol (2010) 1.14
Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes. J Gen Intern Med (2008) 1.14
Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control (2010) 1.13
The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med (2011) 1.12
Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin. World J Gastroenterol (2008) 1.12
Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab (2013) 1.11
The role of metformin in the management of NAFLD. Exp Diabetes Res (2011) 1.09
The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One (2011) 1.08
Contribution of uric acid to cancer risk, recurrence, and mortality. Clin Transl Med (2012) 1.08
Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. Diabetes Technol Ther (2012) 1.07
Collagen as a double-edged sword in tumor progression. Tumour Biol (2013) 1.07
Targeting the insulin growth factor receptor 1. Hematol Oncol Clin North Am (2012) 1.07
Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) (2009) 1.06
The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project. Cancer Causes Control (2012) 1.05
Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis. PLoS One (2014) 1.04
Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. Ann Oncol (2010) 1.03
Diabetes, metformin use, and colorectal cancer survival in postmenopausal women. Cancer Epidemiol (2013) 1.03
Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells. Cell Cycle (2012) 1.03
NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma. Cancer Cell (2013) 1.03
Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Br J Cancer (2013) 1.03
Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2. Mol Cancer (2013) 1.02
Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. World J Gastroenterol (2010) 1.02
Diabetes and thyroid cancer risk: literature review. Exp Diabetes Res (2012) 1.02
A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care (2011) 1.02
Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia. PLoS One (2011) 1.01
Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes. Breast Cancer Res (2012) 1.01
Effects of metformin on CD133+ colorectal cancer cells in diabetic patients. PLoS One (2013) 1.01
Mitohormesis: Promoting Health and Lifespan by Increased Levels of Reactive Oxygen Species (ROS). Dose Response (2014) 1.00
Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China. BMC Public Health (2012) 1.00
Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer. Diabetes Care (2013) 1.00
The insulin receptor: a new target for cancer therapy. Front Endocrinol (Lausanne) (2011) 0.99
Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies. Diabetes Technol Ther (2013) 0.98
Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol (2007) 0.98
Association of type 2 diabetes mellitus and the risk of colorectal cancer: A meta-analysis and systematic review. World J Gastroenterol (2015) 0.97
Metformin use and improved response to therapy in rectal cancer. Cancer Med (2013) 0.97
A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer. Health Qual Life Outcomes (2006) 0.97
Inhibitory effect of metformin therapy on the incidence of colorectal advanced adenomas in patients with diabetes. Intest Res (2015) 0.96
Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies. Gynecol Oncol (2014) 0.95
Pre-existing type 2 diabetes mellitus is an independent risk factor for mortality and progression in patients with renal cell carcinoma. Medicine (Baltimore) (2014) 0.94
Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies. BMC Cancer (2013) 0.94
Effect of diabetes mellitus on outcomes of colorectal cancer. J Korean Soc Coloproctol (2010) 0.94
Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan. BMC Cancer (2014) 0.93
Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies. PLoS One (2013) 0.93
The association of type and number of chronic diseases with breast, cervical, and colorectal cancer screening. J Am Board Fam Med (2014) 0.93
Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis. World J Gastroenterol (2013) 0.92
The links between insulin resistance, diabetes, and cancer. Curr Diab Rep (2013) 0.92
A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk (2012) 0.92
Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation. PLoS One (2014) 0.91
Hyperglycemia, a neglected factor during cancer progression. Biomed Res Int (2014) 0.91
Gene expression profile analysis of type 2 diabetic mouse liver. PLoS One (2013) 0.91
Subclinical hypothyroidism is associated with increased risk for cancer mortality in adult Taiwanese-a 10 years population-based cohort. PLoS One (2015) 0.91
Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer. PLoS One (2013) 0.90
Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey. Cancer Causes Control (2010) 0.90
Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer. Cancer Epidemiol Biomarkers Prev (2016) 0.89
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA (2002) 28.72
Cancer statistics, 2005. CA Cancer J Clin (2005) 25.65
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
Cancer statistics, 2003. CA Cancer J Clin (2003) 13.46
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation (2003) 12.78
Spatial analysis of air pollution and mortality in Los Angeles. Epidemiology (2005) 8.64
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst (2008) 8.14
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality. Res Rep Health Eff Inst (2009) 5.92
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Smoking and mortality--beyond established causes. N Engl J Med (2015) 5.54
The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer (2002) 4.88
Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship. Circulation (2009) 4.84
Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 4.77
American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin (2006) 4.69
Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control (2005) 3.88
Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76
Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol (2010) 3.64
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol (2005) 3.58
Role of smoking in global and regional cardiovascular mortality. Circulation (2005) 3.57
Benefits of smoking cessation for longevity. Am J Public Health (2002) 3.38
Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: shape of the exposure-response relationships. Environ Health Perspect (2011) 3.36
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res (2007) 3.23
Public health benefits of strategies to reduce greenhouse-gas emissions: health implications of short-lived greenhouse pollutants. Lancet (2009) 3.22
Meat consumption and risk of colorectal cancer. JAMA (2005) 3.15
A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
The landscape of recombination in African Americans. Nature (2011) 3.06
Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med (2005) 3.02
Obesity and cancer. Oncogene (2004) 3.01
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96
A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst (2007) 2.95
Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation (2004) 2.91
Pesticide exposure and risk for Parkinson's disease. Ann Neurol (2006) 2.89
Waist circumference and all-cause mortality in a large US cohort. Arch Intern Med (2010) 2.88
Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res (2009) 2.77
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70
Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst (2006) 2.66
Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. Am J Respir Crit Care Med (2011) 2.64
Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer (2005) 2.62
Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiol Biomarkers Prev (2008) 2.58
Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51
Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey. Am J Prev Med (2008) 2.50
Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. Cancer Res (2003) 2.48
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet (2008) 2.45
Cancer statistics for African Americans. CA Cancer J Clin (2002) 2.45
Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8. BMJ (2004) 2.42
Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol Biomarkers Prev (2011) 2.35
Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev (2006) 2.28
Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev (2004) 2.27
Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States. Cancer Epidemiol Biomarkers Prev (2005) 2.19
Long-term trends in cancer mortality in the United States, 1930-1998. Cancer (2003) 2.18
Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev (2005) 2.16
Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort. Obstet Gynecol (2014) 2.11
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst (2011) 2.09
Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med (2003) 2.05
Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene (2002) 2.05
Lung cancer trends in young adults: an early indicator of progress in tobacco control (United States). Cancer Causes Control (2003) 2.02
Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev (2007) 1.91
Spatial analysis of air pollution and mortality in California. Am J Respir Crit Care Med (2013) 1.91
A national framework for cancer surveillance in the United States. Cancer Causes Control (2005) 1.89
Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d. Am J Epidemiol (2009) 1.89
Cancer statistics for Hispanics, 2003. CA Cancer J Clin (2003) 1.88